Investigating the effects of a supported self-management pathway in people who have completed treatment for breast cancer

Not Applicable

Completed

• Conditions: Breast cancer; Cancer; Malignant neoplasm of breast

• Registration Number: ISRCTN10777283
• Lead Sponsor: niversity of Sussex

Brief Summary

2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37698629/ Quality of life and service use results (added 09/10/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37889343/ Patients' views and experiences (added 01/11/2023)

Detailed Description

Not available

Study Timeline

• Study Start: 2020-02-17
• Study Completion: 2021-12-31
• Last Update Posted: 3 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 110

Inclusion Criteria

1. Completed hospital treatment for breast cancer and about to join the supported self-management pathway
2. Attended end-of-treatment appointment and supported self-management workshop/one-to-one consultation
3. Able to read and understand English
4. Willing and able to provide consent
5. Aged 18 years or over

Exclusion Criteria

1. Currently inpatient
2. Acutely distressed for any reason
3. From a hospital outside the Surrey and Sussex Cancer Alliance
4. Do not speak/understand English and have no one to interpret/translate

Study & Design

• Study Type: Observational
• Study Design: Not specified